The protein kinase Cβ-selective inhibitor, enzastaurin, attenuates amphetamine-stimulated locomotor activity and self-administration behaviors in rats

RATIONALE: Pathological amphetamine (AMPH) use is a serious public health concern with no pharmacological treatment options. Protein kinase Cβ (PKCβ) has been implicated in the mechanism of action of AMPH, such that inhibition of PKCβ attenuates AMPH-stimulated dopamine efflux in vivo. With this in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Psychopharmacology (Berl)
Hlavní autoři: Altshuler, Rachel D., Carpenter, Colleen A., Franke, Timothy J., Gnegy, Margaret E., Jutkiewicz, Emily M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6832797/
https://ncbi.nlm.nih.gov/pubmed/31134292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-019-05278-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky